Teriparatide biosimilar (Strides Pharma)
特立帕肽生物类似药 (Strides Pharma)
Report date: 2023/03/08 20:00:33
Base Information
Drug NameTeriparatide biosimilar (Strides Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2023/01/12
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesStrides Pharma
China Registration ClassN/A
Develop Information
Active CompaniesStelis BiopharmaStrides Pharma (Cyprus) Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A